Skip to main content
SpringerLink
Log in

Raising New Hope for Controlling Seizures in Focal Cortical Dysplasia with Gene Therapy

  • Research Highlight
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Almacellas Barbanoj A, Graham RT, Maffei B, Carpenter JC, Leite M, Hoke J. Anti-seizure gene therapy for focal cortical dysplasia. Brain 2024, 147: 542–553.

    Article  PubMed  Google Scholar 

  2. Blümcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011, 52: 158–174.

    Article  PubMed  Google Scholar 

  3. Lim JS, Kim WI, Kang HC, Kim SH, Park AH, Park EK, et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 2015, 21: 395–400.

    Article  CAS  PubMed  Google Scholar 

  4. Zheng Y, Xu C, Sun J, Ming W, Dai S, Shao Y, et al. Excitatory somatostatin interneurons in the dentate gyrus drive a widespread seizure network in cortical dysplasia. Signal Transduct Target Ther 2023, 8: 186.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hsieh LS, Wen JH, Claycomb K, Huang Y, Harrsch FA, Naegele JR, et al. Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement. Nat Commun 2016, 7: 11753.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fujimoto A, Enoki H, Niimi K, Nozaki T, Baba S, Shibamoto I, et al. Epilepsy in patients with focal cortical dysplasia may be associated with autism spectrum disorder. Epilepsy Behav 2021, 120: 107990.

    Article  PubMed  Google Scholar 

  7. Qiu Y, O’Neill N, Maffei B, Zourray C, Almacellas-Barbanoj A, Carpenter JC, et al. On-demand cell-autonomous gene therapy for brain circuit disorders. Science 2022, 378: 523–532.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Snowball A, Chabrol E, Wykes RC, Shekh-Ahmad T, Cornford JH, Lieb A, Hughes MP, et al. Epilepsy gene therapy using an engineered potassium channel. J Neurosci 2019, 39: 3159–3169.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Colasante G, Qiu Y, Massimino L, di Berardino C, Cornford JH, Snowball A, et al. In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy. Brain 2020, 143: 891–905.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Xu C, Zhang S, Gong Y, Nao J, Shen Y, Tan B, et al. Subicular caspase-1 contributes to pharmacoresistance in temporal lobe epilepsy. Ann Neurol 2021, 90: 377–390.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This Research Highlight was supported by grants from the National Natural Science Foundation of China (82330116 and 82374064), and the Natural Science Foundation of Zhejiang Province (LD22H310003).

Author information

Authors and Affiliations

  1. Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Xinhua Hospital of Zhejiang Province, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Hangzhou, 310053, China

    Yuanzhi Yang, Yang Zheng, Zhong Chen & Cenglin Xu

Authors
  1. Yuanzhi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yang Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cenglin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cenglin Xu.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, Y., Zheng, Y., Chen, Z. et al. Raising New Hope for Controlling Seizures in Focal Cortical Dysplasia with Gene Therapy. Neurosci. Bull. (2024). https://doi.org/10.1007/s12264-024-01212-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12264-024-01212-3

Search

Navigation